Some of the markers remained top-ranked of the same direction of regulation even after correction, such as top-up-ranked microglia markers Cd68 and Tyrobp, and astrocyte marker Slc14a1 in the late AD phase remained top-up-ranked after correction. This evidence concerns the gene CD68 and Alzheimer disease.